Experts assess the potential of colchicine 0.5 mg to treat residual risk for atherosclerotic cardiovascular disease (ASCVD) in patients with immune-mediated inflammatory diseases (IMIDs).
A network meta-analysis ranked eight therapies for ulcerative colitis based on how fast they acted to relieve symptoms, with upadacitinib appearing most effective and ozanimod least effective.
GoLocalProv | UnitedHealthcare Tried to Deny Coverage to a College Athlete. He Fought Back. golocalprov.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from golocalprov.com Daily Mail and Mail on Sunday newspapers.
After a college student finally found a treatment that worked, the insurance giant decided it wouldn’t pay for the costly drugs. His fight to get coverage exposed the insurer’s hidden procedures for rejecting claims.